marketcap
Facebook
Twitter
Telegram
Report an ErrorAcceleron Pharma Inc. Financial Ratios 2011-2024 | XLRN
Annual Financial Ratios Acceleron Pharma Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-55.2 | -36.3 | -16.1 | -16.1 | -15.4 | -16.0 | -24.3 | -21.3 | - | - |
P/S |
93.1 | 61.2 | 136.7 | 129.6 | 31.6 | 56.5 | 85.0 | 8.2 | - | - |
EV/EBITDA |
-47.0 | -32.6 | -14.7 | -15.4 | -13.3 | -16.7 | -21.6 | 47.1 | - | - |
PEG |
-4.58 | -4.47 | -4.79 | 0.21 | -0.74 | 0.9 | -0.4 | 0.11 | - | - |
P/B |
8.1 | 10.1 | 6.5 | 4.8 | 3.9 | 9.4 | 8.0 | 8.1 | - | - |
P/CF |
-51.2 | -46.6 | -19.7 | -21.5 | -18.2 | -22.6 | -23.1 | -23.4 | - | - |
ROE % |
-14.60 | -27.78 | -40.70 | -29.70 | -25.27 | -58.48 | -32.80 | -37.88 | - | - |
ROA % |
-13.39 | -24.73 | -37.76 | -27.87 | -23.02 | -43.66 | -27.51 | -17.70 | - | - |
ROCE % |
-15.64 | -28.94 | -42.04 | -29.53 | -28.56 | -46.17 | -28.50 | 7.20 | - | - |
DSO |
- | 42.2 | 183.6 | 96.7 | 42.5 | 73.2 | 84.0 | 23.1 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - |
All numbers in USD currency